Vyome Therapeutics To Begin Trading As Vyome Holdings, Inc. Under Ticker "HIND" On Nasdaq Effective August 15 Following Merger With ReShape Lifesciences

Benzinga · 08/13 15:52

Effective as of Commencement of Trading on August 15, 2025

Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that The Nasdaq Stock Market has approved its listing upon completion of the Company's previously announced merger with ReShape Lifesciences (NASDAQ:RSLS), which is expected to take effect for marketplace purposes with the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol "HIND."